CTOs on the Move

CareSync

www.caresync.com

 
Founded in 2011, CareSync is the leading provider of software and services for chronic disease management, combining technology with 24/7 nursing services to facilitate care coordination among patients, family and caregivers and all providers. CareSync provides turnkey Chronic Care Management services as well as a software-only option, allowing practices of any size to easily meet the billing requirements for CPT code 99490. Additionally, CareSync`s certified technology makes it simple for providers to meet Meaningful Use 2 for Data Exchange, Messaging and Timely Access. CareSync patients are at the center of their healthcare, with access to health information, actionable goals, and ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.caresync.com
  • 2818 Cypress Ridge Blvd Ste 150
    Wesley Chapel, FL USA 33544
  • Phone: 800.587.5227

Executives

Name Title Contact Details

Funding

CareSync raised $18M on 10/07/2015

Similar Companies

Aletheia Therapy

Aletheia Therapy is a group of clinicians dedicated to providing the highest quality psychotherapy and counseling services. They work collaboratively as a practice in order to draw on each therapist’s unique perspective and expertise to most effectivel...

ISOAID

ISOAID is a Port Richey, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bryan Health

Bryan Health is a not-for-profit healthcare system with two acute care facilities in Lincoln, a critical access hospital in Crete, outpatient clinics, and a statewide network that provides sophisticated mobile diagnostic treatment and services to citiz...

Humacyte

Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.

Siegfried USA

Siegfried USA is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Pennsville, NJ. To find more information about Siegfried USA, please visit www.siegfried-usa.com